Home
About us
Services
Contact us!
Publications
Our clients
Recent Presentations


Advantages for Establishing an IVIVC for MR Products
Seminar of the Joint Pharmaceutical Analysis Group
London, (June 15, 2006)
Harald Rettig, Ph.D.


Applications for the Robust IVIVC
Workshop on in vitro-in vivo correlation
Geneva (September 21-22, 2005)
Harald Rettig, Ph.D.


In vitro-in vivo Correlation as a Tool to Predict in vivo Data
Dissolution, Bioavailability & Bioequivalence
Amsterdam, (September 14-16, 2005)
Jana Mysicka


The IVIVC in Product Development
Increasing Efficiency for the Film-coating Process
Wurzburg, (June 8-9, 2005)
Harald Rettig, Ph.D.


IVIVC based Biowaivers
Biowaivers: Requirements, Opportunities, and Experience
Budapest, (April 28, 2005)
Harald Rettig, Ph.D.


In vitro Performance Criteria
Dissolution Rate: Quality and Bioequivalence
Rome, (March 4, 2005)
Harald Rettig, Ph.D.


Establishing the validity of an IVIVC
IVIVC Conference: IVIVCs in drug development
Brussels, (June 23-25, 2003)
Jana Mysicka


Design Elements of the Bioavailability/Bioequivalence for an IVIVC
APV Workshop on IVIVC, No. 586
Bremen, D (10-11.February, 2003)
Harald Rettig, Ph.D.


Validity of an IVIVC: Internal and External Predictability
APV Workshop on IVIVC, No. 586
Bremen, D (10-11.February, 2003)
Jana Mysicka


Der Nutzen einer IVIVC in verschiedenen Phasen der Produktenentwicklung
APV Workshop: Dissolution Workshop für Fortgeschrittene
Nürnberg, D (10-11. Dezember, 2002)
Harald Rettig, Ph.D.


IVIVC: Examples of Standard and Non-Standard Approaches
IVIVC Conference: Best Practice In Vitro-In Vivo Correlation
London, UK, (November 18-19, 2002)
Jana Mysicka


Dissolution as Surrogate for Bioavailability Testing: the Application of IVIVC
DIA Workshop: Drug Dissolution Testing: Current Status and Future Challenges
London, UK (June 18-19, 2001)
Harald Rettig, Ph.D.


Development and Validation of an in vitro-in vivo Correlation for an Acyclovir Controlled
Release Formulation

3rd World Meeting on Pharmaceutics, Biopharmaceutics, Pharmaceutical Technology
Berlin, Germany (April 3-6, 2000)
Jana Mysicka


Applying the IVIVC Methodology for Nicotine Containing Chewing Gums as a Basis for a
Biowaiver and for Setting Meaningful Release

AAPS Annual Meeting 1999
New Orleans (U.S.A, November, 1999)
Jana Mysicka


Dissolution as Surrogate for Bioavailability Testing: The Application of IVIVC
DIA Workshop
Toronto, Canada (October 4-5, 1999)
Harald Rettig, Ph.D.


In vitro-in vivo Correlations and New Generic Drug Applications
The Fourth Annual Henry Stewart Conference on Uderstanding Bioequivalence and
Therapeutic Equivalence
London, UK (October 26-27, 1999)
Jana Mysicka


IVIVC in International Guidelines: Key Terms and Principles
APV Course No. 389
Eisenach, Germany, (September 13-14, 1999)
Harald Rettig, Ph.D.


IVIVC as a Basis for a Biowaiver and for Setting in vitro Release Specifications for Nicotine
Chewing Gums

APV Course No. 389
Eisenach, Germany, (September 13-14, 1999)
Jana Mysicka


FDA and European Agency Guidelines for in vitro-in vivo Correlations between Dissolution
Data and Plasma Profiles

Conference on Bioequivalence & Bioavailability. Regulatory / Scientific Concepts
and Implications, organized by ACDIMA
Tunis, (November 28-29, 1998)
Harald Rettig, Ph.D.


IVIVC between Dissolution Data and Plasma Profiles from a Scientific Perspective
Conference on Bioequivalence & Bioavailability. Regulatory / Scientific Concepts
and Implications, organized by ACDIMA
Tunis, (November 28-29, 1998)
Jana Mysicka


Development Evaluation of an in vitro-in vivo Correlation Level A for a Class II Drug Product
AAPS Annual Meeting 1998
San Francisco, US
Jana Mysicka


Setting In vitro Dissolution Specifications for a CR Product by Using In vitro-In vivo Relationship
AAPS Annual Meeting 1997
Boston, US
Jana Mysicka


< Home | About us | Services | Presentations | Contact us | Publications | Our Clients >